Increased p16INK4a, p14ARF, and p15INK4b and decreased class I and II HDACs to inhibit cell growth and induce apoptosis in pancreatic cancer AsPC-1 and colon cancer HCT-116 cell lines (47). Here, CDKN2B is linked to pancreatic neoplasm.